|
|
| Santaris Pharma is dedicated to the exciting new field of RNA therapeutics, and is ready to deliver on the promise of the technology today. Our proprietary Locked Nucleic Acid Drug Platform and state-of-the-art Drug Discovery Engine are transforming the field of RNA based medicines, making safe and effective modulation of disease-related RNAs an achievable goal. |
|
| The Company's drug development pipeline is focused on improving the treatment and outcome of patients with metabolic disorders and infectious diseases. In collaboration with our strategic partners, we are engaged in a broad array of additional therapeutic areas such as cancer and inflammatory diseases. |
|
| |
|
read more about santaris pharma |
|
|
|
|
|
|